GSK enters agreement to acquire 35Pharma Inc.

Health

Gsk Enters Agreement To Acquire 35Pharma Inc.

By GSK

Acquisition includes HS235, a potentially best-in-class activin signalling inhibitor in clinical development for treatment of cardiopulmonary diseases HS235 offers potential to treat pulmonary hypertension (PH) patients while reducing the risk of ble ...Read more

Related Posts

Doctors implant dopamine-producing stem cells in Parkinson’s patients

Doctors implant dopamine-producing stem cells in Parkinson’s patients

Feb 20, 2026
Sleep Apnea Symptoms Women Over 50 Should Never Ignore

Sleep Apnea Symptoms Women Over 50 Should Never Ignore

Feb 24, 2026
Newlywed dies from sepsis. What is it?

Newlywed dies from sepsis. What is it?

Feb 19, 2026
Casey Means, Critic of Mainstream Medicine, May Become Nation’s Top Doctor

Casey Means, Critic of Mainstream Medicine, May Become Nation’s Top Doctor

Feb 25, 2026
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.